# US 2012/0252121 A1 · Culture Method for Amplifying Large Numbers of Hair Follicle Stem Cells in Vitro

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252121 A1
- Document ID: US20120252121A1
- Status: Published application
- Kind: A1
- Application number: 13/517,068
- Filed: 2011-07-20
- Published: 2012-10-04
- Earliest claimed: 2010-07-22
- Assignees: Jilin University
- Inventors: Jinyu Liu; Yulin Li
- Web page: https://patentgrep.com/patent/US20120252121A1

## CPC

- C12N 5/0666: {Mesenchymal stem cells from hair follicles}
- C12N 2531/00: Microcarriers
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention is a method, belonging to the field of cell culture, for amplifying a large numbers of hair follicle stem cells in vitro by using microspheres as carriers for cell culture and a revolving bottle as a fermentation tank for cell proliferation. The method is simple in its procedures, is economical and practical, and avoids side effects associated with the traditional cell amplification method, such as the weakening of cell proliferation capability, the reduction of differentiation potential and the like caused by repeated cell subculture, and also reduces the consumption of the culture solution; the hair follicle stem cells amplified by the method can still keep the original proliferation capability and differentiation potential, and can be used for: (1) establishing hair follicle stem cell bank to provide high-quality seed cells for related research on adult stem cells; (2) transplanting and repairing tissues and organs subjected to pathological changes; (3) constructing tissue-engineered organs to be used as substitute autologous organs for transplantation or repair of organs subjected to pathological changes or missing organs; and (4) serving as target cells for the genetic treatment of corresponding diseases.

## Claims

### Claim 1

A method for amplifying large numbers of hair follicle stem cells in vitro, composing the following steps:
(1) digesting hair follicles or hair follicle tissue blocks in the presence of protease to obtain the cells, seeding the said cells, to microcarriers, with a density range from 1×103 cells/g microcarrier to 1×108 cells/g microcarrier, and then suspending them in the liquid culture media;
(2) transfering the said microcarriers, together with the cells on them, into a revolving bottle;
(3) according to the volume of the said revolving bottle, feeding the said liquid culture media into the said revolving bottle to 1/10-⅓ of the said volume;
(4) placing the said revolving bottle into cell incubator for cell culture, under the conditions of 37° C., 5v/v % CO2, the said revolving bottle rotates 1-5 minutes every hour, and the rotation speed is 10-300 rounds/min;
(5) using digestive agent to digest the said cells from the said microcarriers, when the said cells have nearly grown to a monolayer on the microcarriers, and then, inactivating the said trypsin by using serum, and after washing away serum and antibiotics by using phosphate buffer solution, the amplified hair follicle stem cells will be harvested;

### Claim 2 (depends on 1)

The method of claim 1, wherein the said digestive agent is the solution with 0.25% trypsin and 0.02% EDTA.

### Claim 3 (depends on 1)

The method of claim 1, wherein the said liquid culture media selects from DMEM, DMM-F12, EGM, KGM, IMDM, MEM or EBM as basal media, and contains a mixture of one or more biological factors.

### Claim 4 (depends on 3)

The method of claim 3, wherein the said biological factors select from IGF, bFGF, EGF, VEGF, Phosphate vitamin C, dexamethasone, insulin, transferrin, animal pituitary extract, penicillin-streptomycin, amphotericin, human serum or animal serum.

### Claim 5 (depends on 4)

The method of claim 4, wherein the said animal serum selects one or several from the serum consisting of bovine serum, sheep serum and pig serum.

### Claim 6 (depends on 1)

The method of claim 1, wherein the said microcarriers are the material, consisting of one or several kinds of biodegradable materials, or consisting of non-biodegradable materials or consisting of biodegradable materials and non-biodegradable materials, for cell culture,

### Claim 7 (depends on 6)

The method of claim 6, wherein the said biodegradable materials select from collagen, blood fibrinolytic protein, gelatin, hyaluronic acid, polylactic acid, poly glycolic acid, polyurethane or chitosan.

### Claim 8 (depends on 6)

The method of claim 6, wherein the said non-biodegradable materials select from glass, silicone, metal and plastics.

### Claim 9 (depends on 1)

The method of claim 1, wherein the said microcarriers are spherical or ellipsoidal particles, with an average particle size range from 10 μm to 1000 μm.

### Claim 10 (depends on 1)

The method of claim 1, wherein the said microcarriers are spherical or ellipsoidal particles, with an average particle size range from 100 μm to 800 μm.
